PI
CRL icon

Placemark Investments’s Charles River Laboratories CRL Stock Holding History

Placemark Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,753
Closed -$200K – 1633
2014
Q2 		$200K Sell
3,753
-984
-21% -$54K ﹤0.01% 1568
2014
Q1 		$282K Sell
4,737
-740
-14% -$43.1K 0.01% 1371
2013
Q4 		$291K Buy
5,477
+88
+2% +$4.42K ﹤0.01% 1371
2013
Q3 		$247K Sell
5,389
-1,083
-17% -$49.7K ﹤0.01% 1394
2013
Q2 		$265K Buy
+6,472
New +$277K 0.01% 1337

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Placemark Investments's CRL Position: Q3 2014 in Review

Placemark Investments sold out of Charles River Laboratories (CRL) in Q3 2014, closing a stake of 3,753 shares — an estimated $200K sold.

Placemark Investments first reported a position in CRL in Q2 2013 and held it in 5 quarters. The position peaked at $291K in Q4 2013. 255 funds tracked by Wall St. Rank hold CRL as of Q3 2014.

  • Placemark Investments reported no remaining Charles River Laboratories position as of Q3 2014 after selling out during the quarter.
  • Placemark Investments sold 3,753 Charles River Laboratories shares in Q3 2014, an estimated $200K.
  • Placemark Investments first reported a position in Charles River Laboratories in Q2 2013 and held it in 5 quarters.
  • Placemark Investments's Charles River Laboratories position peaked at $291K in Q4 2013.
  • 255 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2014.

Based on Placemark Investments's 13F filing for Q3 2014, filed 14 Nov 2014.